Orphazyme finds reduced Niemann-Pick disease progression in trial
Biopharmaceutical firm Orphazyme has reported positive interim results from an open-label extension study of a...
Read More...
Focus:
Denmark
-
![Bavarian Nordic reports Phase III data for smallpox vaccine Jynneos]()
Bavarian Nordic reports Phase III data for smallpox vaccine
Bavarian Nordic has reported data from the Phase III efficacy study of MVA-BN (Jynneos) vaccine,...
Read More...
-
![Bavarian Nordic reports Phase II bladder cancer study data]()
Bavarian Nordic reports Phase II bladder cancer trial data
Bavarian Nordic has reported results from the first stage of a Phase II clinical trial...
Read More...
-
![Bavarian Nordic begins equine encephalitis virus vaccine trial]()
Bavarian Nordic begins equine encephalitis virus vaccine trial
Bavarian Nordic has started a Phase I clinical trial to assess its vaccine candidate MVA-BN...
Read More...
-
Zealand reports results of paediatric Phase 3 trial for hypoglycaemia
Denmark-based biotechnology company Zealand Pharma has reported positive outcome for its dasiglucagon in the paediatric...
Read More...
-
![oral semaglutide]()
Novo Nordisk reports positive data for oral semaglutide
Novo Nordisk has reported positive results from the Phase IIIa PIONEER clinical trial programme of...
Read More...
-
MC2 Therapeutics enrols patents for trial of MC2-01 PAD Cream
MC2 Therapeutics has completed enrollment for its Phase III study of MC2-01 PAD Cream to...
Read More...
-
Gilead and Novo partner to trial combination therapy for NASH
Gilead Sciences has entered a clinical collaboration with Denmark-based Novo Nordisk to evaluate a combination...
Read More...
-
![]()
Janssen to study daratumumab in Phase III trial
Danish biotechnology firm Genmab has announced that Janssen Biotech will conduct a Phase III clinical...
Read More...
-
Ascendis Pharma reports positive results from heiGHt trial
Ascendis Pharma has reported positive results from its pivotal Phase III heiGHt trial evaluating TransCon...
Read More...